CRISPR-Cas systems recognize an invading phage by comparing its genetic material with a guide RNA called a crRNA. The guide supplies sequence specificity; the Cas effector checks the matching DNA or RNA in a way that depends on the CRISPR system. Many DNA-targeting systems also require a nearby PAM sequence, while some systems recognize RNA directly.
How does a CRISPR guide identify a phage sequence?
A bacterium stores short pieces of genetic material from past invaders as spacers in a CRISPR array. The array is expressed and processed into CRISPR RNAs (crRNAs). Each crRNA carries a sequence copied from an earlier invader, so it can base-pair with a complementary sequence in a later infection. Cas proteins bind the crRNA and use it to search for a matching target.
As an Amazon Associate I earn from qualifying purchases.
This is sequence-guided recognition, not a general ability to identify anything that looks like a virus. The match is interpreted in context: DNA-targeting effectors often require a nearby protospacer-adjacent motif, or PAM, and RNA-targeting systems have their own recognition rules. Recognition is also distinct from what happens next. Depending on the effector, a successful match can lead to DNA degradation, RNA cleavage, or additional immune signaling.
How do DNA-targeting systems recognize phage DNA?
In representative type I and type II systems, the crRNA directs an effector to a DNA sequence complementary to its guide. Many such systems first check for a PAM next to the target sequence, called a protospacer in the invading genome. PAM sequences differ among systems; there is no single PAM shared by all CRISPR-Cas pathways.
Type I: Cascade recruits Cas3
In a representative type I system, a multi-protein complex called Cascade carries the crRNA and samples DNA. Recognition of a compatible PAM helps Cascade bend and open the DNA. If the adjacent sequence also matches the guide, the crRNA pairs with one DNA strand and displaces the other, forming an RNA-DNA hybrid structure called an R-loop. That recognition changes the complex so it can recruit Cas3, whose helicase and nuclease activities degrade the target DNA.
Type II: Cas9 cuts the target DNA
Cas9, the characteristic effector in type II systems, is a single-protein example of DNA targeting. It recognizes a PAM beside the target, then guide pairing opens the DNA and forms an RNA-DNA hybrid. After productive target recognition, Cas9’s two nuclease domains cut the DNA strands. The exact PAM requirement depends on the system.
Why the PAM helps distinguish invader DNA from the CRISPR array
The host’s CRISPR array contains the spacer sequence that matches the invader, but it is not flanked by the same PAM context expected beside a phage protospacer. For PAM-dependent systems, this neighboring-sequence check helps avoid attacking the host’s own array while enabling recognition of matching invading DNA. It is one safeguard, not a universal rule: PAM dependence and recognition mechanisms vary across CRISPR types and subtypes.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Clear out junk files and repair common Windows errors3Fix the driver behind crashes, sound loss and screen glitchesHow do RNA-targeting systems recognize phage RNA?
Some CRISPR effectors search RNA directly rather than first recognizing phage DNA. In this context, “phage RNA” usually means RNA transcribed from an invading DNA genome. RNA-targeting pathways may also act against RNA viruses. A matching crRNA guides the effector to complementary RNA, but the consequences of binding depend on the system.
Type III: RNA recognition can trigger more than RNA cleavage
Type III complexes, including Csm and Cmr examples, recognize transcripts complementary to their crRNA. Target binding can lead to RNA cleavage. In characterized systems it can also activate Cas10 functions, including single-stranded DNA cleavage and production of cyclic oligoadenylate signaling molecules. Those signals can activate auxiliary nucleases and broaden the response beyond the initially recognized transcript.
Thus, a type III system can target RNA and DNA. RNA recognition is the trigger described here; DNA cleavage and signaling are additional, system-dependent activities rather than properties of every CRISPR system.
Rank #4
- Investigate the building blocks of life and learn the ABC's of DNA!
- Isolate plant DNA in a test tube.
- Learn about biological inheritance.
- Assemble a DNA model to see its elegant double-stranded helical structure.
- A 48-page, full-color manual guides you through 20 experiments and teaches about the basics of genetics and DNA.
Type VI: Cas13 recognizes RNA
Type VI effectors such as Cas13 target RNA. When a complementary target binds, Cas13’s nuclease activity can cleave that RNA. In characterized systems, target recognition can also activate cleavage of other accessible RNA molecules, known as collateral cleavage. That broader activity can disrupt cellular RNA and contribute to stopping infection, but it is not the same thing as the initial sequence-specific guide match, and it should not be assumed for every CRISPR pathway.
How the main recognition strategies compare
| Representative system | Target recognized | Recognition context | What can follow recognition |
|---|---|---|---|
| Type I | DNA | In representative systems, Cascade checks a PAM and then pairs the crRNA with matching DNA. | Cas3 is recruited to degrade the target DNA. |
| Type II (Cas9) | DNA | Cas9 checks a PAM beside the matching target DNA. | Cas9 cuts both DNA strands after productive recognition. |
| Type III (Csm/Cmr examples) | RNA and, in some pathways, DNA | The crRNA guides the complex to complementary RNA; rules differ from PAM-based DNA recognition. | RNA cleavage; in characterized systems, DNA cleavage and cyclic-oligonucleotide signaling can also occur. |
| Type VI (Cas13) | RNA | Cas13 binds RNA complementary to its crRNA. | Target RNA cleavage and, in characterized systems, collateral RNA cleavage. |
These are representative examples, not a complete map of every subtype. The table separates the target that the guide helps recognize from the effector’s downstream response; neither a PAM requirement nor collateral activity applies universally.
Why can a matching phage still evade CRISPR?
A matching sequence is necessary for guide-directed recognition, but it does not guarantee that an effector can reach or attack the target. The relevant substrate must be accessible, and the target must satisfy the recognition rules of that particular system. Phages can differ in how they expose their genetic material during infection.
One example discussed in reviews of RNA-targeting CRISPR systems is a jumbo phage that forms a nucleus-like compartment. The compartment hinders DNA-targeting systems, while RNA made during infection remains vulnerable to type III RNA-based immunity. The example illustrates why target accessibility and effector type matter alongside sequence complementarity; it does not mean RNA targeting always defeats such compartments.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
